Rituxan (rituximab) - Roche
tegoprubart (AT-1501) - Eledon
Atgam (equine anti-thymocyte globulin) - Pfizer
siplizumab (TCD601) - ITBMed
cyclophosphamide - Generic mfg.
Tolerance Through Mixed Chimerism (Sip-Tego) (clinicaltrials.gov) - Sep 26, 2026 - P1 | N=12 | Active, not recruiting | Sponsor: Tatsuo Kawai, MD, PhD | Recruiting ➔ Active, not recruiting 
Enrollment closed • Renal Disease • Transplantation
http://clinicaltrials.gov/ct2/show/NCT06972069
 
Sep 26, 2026
 
Prev Next